logo Diatech Pharmacogenetics

Explore EasyPGX® Ready

the comprehensive IVD portfolio for solid and blood cancer biomarkers.

EasyPGX® Ready combines dedicated assays for both solid and hematologic malignancies in one streamlined platform with a simplified workflow. Discover the all-in-one qPCR solution designed to advance precision medicine.

EasyPGX® Ready solid tumor portfolio

Thyroid
Cancer

KRAS, BRAF, NRAS,
RET, HRAS, PPARG

Non-Small Cell
Lung Cancer

KRAS, BRAF, EGFR,
ALK, ROS1, RET, MET

Colorectal
Cancer

KRAS, BRAF, NRAS,
MSI, MLH1, РІКЗСА

Urothelial
Cancer

FGFR2-3

Melanoma

BRAF, NRAS

Liquid Biopsy
Assays

KRAS, BRAF, EGFR,
NRAS, PIK3CA, ESR1

Pharmacogenetics

DPYD, UGT1A1

Tumour-Agnostic
Biomarkers

MSI, NTRK,
RET, BRAF

Head and
Neck Cancer

HPV, HRAS

Cholangiocarcinoma

IDH1-2, FGFR2,
KRAS, BRAF

Gynecologic
Cancers

HPV, MSI, MLH1

Breast
Cancer

РІКЗСА, ESR1

Glioma

BRAF, IDH1-2,
MGMT

Thyroid Cancer

KRAS, BRAF, NRAS, RET, HRAS, PPARG

Non-Small Cell Lung Cancer

KRAS, BRAF, EGFR, ALK, ROS1, RET, MET

Colorectal Cancer

KRAS, BRAF, NRAS, MSI, MLH1, РІКЗСА

Urothelial Cancer

FGFR2-3

Melanoma

BRAF, NRAS

Liquid Biopsy Assays

KRAS, BRAF, EGFR, NRAS, PIK3CA, ESR1

Pharmaco-genetic

DPYD, UGT1A1

Tumour-Agnostic Biomarkers

MSI, NTRK, RET, BRAF

Head and Neck Cancer

HPV, HRAS

Head and Neck Cancer

HPV, HRAS

Cholangio-carcinoma

IDH1-2, FGFR2, KRAS, BRAF

Gynecologic Cancers

HPV, MSI, MLH1

Breast
Cancer

РІКЗСА, ESR1

Glioma

BRAF, IDH1-2, MGMT

Discover more
Keep in contact

EasyPGX Ready Blood cancer portfolio

Diagnosis & Prognosis

BCR-ABL

AML1-ETO

CBFB-MYH11

PML-RARA

IDH1-2

NPM1

MRD Monitoring

BCR-ABL p210

BCR-ABL p190

NPM1

WT1

Discover more